Full Text
EE226 Cost-Effectiveness Analysis of Fixed-Dose Triple Combination Therapy (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) Vs. Its Fixed-Dose Double Combination and Individual Components

Abstract

Authors

D. Winberg L. Shi

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×